Buspirone Hydrochloride
Product Images NDC 50436-0182

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 50436-0182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (2a7745f5 4376 4a0a B040 Fdd441205d8d 01)

Structural Formula (2a7745f5 4376 4a0a B040 Fdd441205d8d 01)
Chemical structure of Buspirone hydrochloride. The diagram shows the molecular connectivity, including a piperazine ring, a cyclohexane-dione moiety, and a pyrimidinyl group with a hydrochloride salt indicated.*
FDA Label Image

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 02)
An illustration showing dosing instructions for Buspirone hydrochloride tablets in 15 mg and 30 mg strengths. It depicts tablet segments representing various doses with markings: '5', 'ZE 38' for 15 mg tablets and '10', 'ZE 39' for 30 mg tablets. The diagram explains tablet divisions for 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, and 30 mg doses by showing whole tablets, halves, thirds, and two-thirds sections.*
FDA Label Image

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 03)

Figure (2a7745f5 4376 4a0a B040 Fdd441205d8d 03)
Image of two fingers holding a small, white, oblong tablet. The tablet has an imprint, but details of the imprint are not clearly visible. The product is Buspirone hydrochloride, distributed by Unit Dose Services, associated with NDC 50436-0182.*
FDA Label Image

Label Image (Lbl504360182)

Label Image (Lbl504360182)
Buspirone hydrochloride 15 mg tablet label from Unit Dose Services. The label includes NDC 50436-0182-1, dosage of 15 mg per tablet, and a package size of 30 tablets. It contains storage instructions, manufacturing details by Cadila Healthcare Ltd., and warnings to keep out of reach of children. The label also notes the product is prescription-only (RX ONLY).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.